Vestmark Advisory Solutions, Inc. Bio N Tech Se Transaction History

Vestmark Advisory Solutions, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$126.25 - $231.85 $230,027 - $422,430	-1,822 Closed	0 $0
Q4 2021 Jan 31, 2022	SELL	$216.64 - $362.52 $27,729 - $46,402	-128 Reduced 6.56%	1,822 $470,000
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $249,381 - $541,595	-1,211 Reduced 38.31%	1,950 $532,000
Q2 2021 Aug 09, 2021	BUY	$113.32 - $241.49 $113 - $241	1 Added 0.03%	3,161 $708,000
Q1 2021 May 10, 2021	BUY	$85.73 - $119.5 $270,906 - $377,620	3,160 New	3,160 $345,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.